Title:
DRUG COMPRISING ARIPIPRAZOLE AND CILOSTAZOL
Document Type and Number:
WIPO Patent Application WO/2017/111123
Kind Code:
A1
Abstract:
The present invention enables treatment and/or prevention of dementia, cognitive impairment, and vascular depression by a combination of aripiprazole and cilostazol, or the like. The combination contains aripiprazole and cilostazol, and is used for the treatment and/or prevention of at least one member selected from the group consisting of dementia, cognitive impairment, and vascular depression.
Inventors:
SHIN HWA KYOUNG (KR)
CHOI BYUNG TAE (KR)
HONG KI WHAN (KR)
CHOI BYUNG TAE (KR)
HONG KI WHAN (KR)
Application Number:
PCT/JP2016/088554
Publication Date:
June 29, 2017
Filing Date:
December 22, 2016
Export Citation:
Assignee:
OTSUKA PHARMA CO LTD (JP)
International Classes:
A61K31/496; A61K31/4709; A61P9/10; A61P25/14; A61P25/16; A61P25/24; A61P25/28
Foreign References:
| US20150152084A1 | 2015-06-04 |
Other References:
KIM, YU RI ET AL.: "Studies on the animal model of post-stroke depression and application of antipsychotic aripiprazole", BEHAVIOURAL BRAIN RESEARCH, vol. 287, pages 294 - 303, XP055395745, ISSN: 0166-4328
TAKAHASHI, K. ET AL.: "Novel Augmentation Therapy with Cilostazol for the Geriatric Major Depressive Disorder Patient with Deep White Matter Hyperintensities on T2-Weighted Brain MRI: A Case Report", PHARMACOPSYCHIATRY, vol. 41, 2008, pages 37 - 39, ISSN: 0176-3679
TAKAHASHI, K. ET AL.: "Novel Augmentation Therapy with Cilostazol for the Geriatric Major Depressive Disorder Patient with Deep White Matter Hyperintensities on T2-Weighted Brain MRI: A Case Report", PHARMACOPSYCHIATRY, vol. 41, 2008, pages 37 - 39, ISSN: 0176-3679
Attorney, Agent or Firm:
SAEGUSA & PARTNERS (JP)
Download PDF: